Publikationen

Byrski, Dennis; Gaessler, Fabian; Higgins, Matthew John (2021). Market Size and Research: Evidence from the Pharmaceutical Industry Max Planck Institute for Innovation & Competition Research Paper No. 21-16.

Muñoz Ferrandis, Carlos Data Sharing: Are You Holding or Enabling? Lvcentinvs Blog 2021.

Klimm, Felix; Kocher, Martin G.; Opitz, Timm; Schudy, Simeon Andreas (2021). Time Pressure and Regret in Sequential Search (CESifo Working Paper No. 9122 ).

Kleine, Marco (2021). No eureka! Incentives Hurt Creative Breakthrough Irrespective of the Incentives' Frame Max Planck Institute for Innovation & Competition Research Paper No. 21-15.

Kaiser, Ansgar De minimis Uses and the German Implementation of Art 17 DSM Directive The IPKat - Blog 2021.

Mueller-Langer, Frank; Watt, Richard (2021). Optimal Pricing and Quality of Academic Journals and the Ambiguous Welfare Effects of Forced Open Access: A Two-Sided Model Managerial and Decision Economics 2021.

Wang, Lucy Xiaolu (2021). The Complementarity of Drug Monitoring Programs and Health IT for Reducing Opioid-Related Mortality and Morbidity Max Planck Institute for Innovation & Competition Research Paper No. 21-14.

Hilty, Reto M. Covid-19 and the Role of Intellectual Property - Position Statement of the Max Planck Institute for Innovation and Competition of 7 May 2021 2021, 11 S. (gemeinsam mit Pedro Henrique D. Batista et al.).

Beneke Ávila, Francisco Competition Law and Political Influence of Large Corporations – Antitrust Analysis and the Link between Political and Economic Institutions (Max Planck Institute for Innovation & Competition Research Paper, No. 21-12), 2021, 23 S.

Muñoz Ferrandis, Carlos Fintech Sandboxes and Regulatory Interoperability RegTrax Blog, Stanford Law School 2021.